Clinical Trial Update: A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial update on PM012 tablet for Alzheimer's disease assessing optimal dosage/administration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• PM012 Tablet (PM012)

Snippet

Sponsor: Mediforum Ltd., Co. | Conditions: Mild Alzheimer Disease | Phase 2, Phase 3 | Status: UNKNOWN